mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.73 |
0.003 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.005 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.006 |